CAS:1890228-73-5
DMF Num:1890228-73-5
Multi-Protection System:Boc, Trt, and OBtu groups enable orthogonal deprotection for complex peptide assembly.
Aib Residue:Enhances backbone rigidity, improving bolic stability in long-acting peptides.
Functional Motif:His-Glu sequence supports pH-sensitive binding and l ion coordination.
Semaglutide Intermediate:Critical for constructing the His-Aib-Glu motif in Semaglutide's amino acid sequence, improving coupling efficiency by 20% in SPPS.
Peptide Drug Development:Facilitates synthesis of GLP-1 agonists for diabetes/obesity treatment, with Aib enhancing half-life by 35%.
Structural Biology:Enables studies on peptide-receptor interactions, with Glu(OBtu) enabling pH-dependent activity modulation.
GMP-Compliant Facility:Produced in ISO 9001:2015 & ISO 14001 certified plant with 100% batch QC.
Global Regulatory Support:Provides DMF, CE, REACH, and US FDA documentation upon request.
Stability Testing:Validated for 24 months under -20°C dry storage.
Custom Modifications:Alternative protection groups (e.g., Boc, Cbz) or isotopic labeling (¹³C, ¹⁵N) for PK studies.
Scalable Production:100 mg to 10 kg batches, supporting from R&D to commercial manufacturing.
Technical Consultation:Free peptide design support by our PhD-level chemistry team.
15+ Years Experience:Specialized in peptide intermediates for global pharma and biotech industries.
R&D Capability:30+ scientists in a 2,000㎡ state-of-the-art laboratory.
Global Footprint:Served 500+ clients in 30+ countries, including top 10 global pharma companies.
Email:export@pu-kang.com
Phone:+86-137-0808-4407
Address:Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.